Stamford Pharmacy Agrees to Pay Fine for Violating Federal Drug Laws

Stamford Pharmacy has entered into a civil settlement with the federal government — including paying a $45,000 fine, to resolve allegations that it violated civil provisions of the Controlled Substances Act.

Connecticut’s United States Attorney Deirdre M. Daly announced the settlement with the pharmacy located at 1055 High Ridge Rd. on Tuesday.

The allegations against Stamford Pharmacy included claims that they failed to promptly file theft and loss reports of controlled substances with the Drug Enforcement Administration in at least 17 separate instances as required by law and that they failed to keep current, complete, and accurate controlled substance records of each controlled substance purchased and dispensed.

Congress, with the passage of the Controlled Substances Act, took steps to create “a closed system” of distribution for controlled substances in which every facet of the handling of the substances, from their manufacture to their consumption by the ultimate user, was to be subject to intense governmental regulation, according to Daly’s office.

The investigation was conducted by investigators from the Drug Enforcement Administration’s Office of Diversion Control in Rocky Hill, and the Drug Control Division of the state Department of Consumer Protection. The prosecution was led by Assistant U.S. Attorney Alan M. Soloway.

Photo credit: stamfordpharmacy.com.